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Blood Pressure Variability in Children With Primary vs Secondary
Hypertension
Daniel Leisman, BS; Melissa Meyers, MD; Jeremy Schnall, MD; Nataliya Chorny, MD; Rachel Frank, RN; Lulette Infante, RN;
Christine B. Sethna, MD, EdM
From the Division of Pediatric Nephrology, Department of Pediatrics, Cohen Children’s Medical Center of New York, New Hyde Park, NY

Increased blood pressure variability (BPV) is correlated with
adverse cardiovascular (CV) events in adults. However,
there has been limited research on its effect in the pediatric
population. Additionally, BPV differences between primary
and secondary hypertension (HTN) are not known. Children
with primary and secondary HTN underwent 24-hour ambulatory blood pressure monitoring and echocardiography
studies. BPV measures of standard deviation (SD), average
real variability (ARV), and range were calculated for the 24hour, daytime, and nighttime periods. Seventy-four patients
(median age, 13.5 years; 74% boys) were examined, 40 of
whom had primary HTN. Body mass index z score and age
were independent predictors of systolic ARV (R2=0.14) and
SD (R2=0.39). There were no statistically significant differences in overall or wake period BPV measures between
secondary or primary HTN groups, but sleep period diastolic

SD was significantly greater in the secondary HTN group
(9.263.8 vs 7.12.8, P=.039). On multiple regression
analysis, secondary HTN was associated with increased
sleep period diastolic SD (P=.025). No metrics of BPV in the
overall, wake, and sleep periods were found to be significantly associated with left ventricular hypertrophy (LVH). The
results of this study do not show a strong relationship
between overall or wake BPV with primary vs secondary
HTN, but the association of secondary HTN with sleep
period diastolic BPV deserves further exploration. Contrary
to expectation, the findings of this study failed to indicate a
relationship between BPV and LVH for all patients as well for
primary hypertensive and secondary hypertensive patients.
J Clin Hypertens (Greenwich). 2014;16:437–441. ª2014
Wiley Periodicals, Inc.

Hypertension (HTN) has long been considered a precursor to cardiovascular (CV) morbidity and mortality.
HTN can be described as either primary or secondary to
another cause or condition; the latter having greater
association with elevated nocturnal blood pressure (BP),
reduced nocturnal dip, and other risk factors for adverse
events.1,2 Independent of elevated BP readings, however,
BP variability (BPV)—the degree of variation between
discrete BP readings—has recently been shown to be
associated with a myriad of unfavorable outcomes
including adverse CV events, progression of renal disease,
impaired endothelial function, and all-cause morbidity
and mortality.2–12 Specifically, a greater degree of BPV,
measured from systolic values in particular, has been
found to be predictive of these events, independent of
hypertensive status.4,7–9 The relationship between BPV
and primary vs secondary HTN is unknown.
While BPV has been the subject of investigation in
adults, there has been quite limited research into its
effect in the pediatric population. HTN in children and
adolescents has been well correlated with surrogate
outcomes of higher body mass index (BMI), left
ventricular hypertrophy (LVH), and early coronary
artery disease.13 However, given that most severe

adverse CV events are generally the product of many
years of strain to the vascular system, these outcomes
are seen rarely in children. Nevertheless, the consequences of years of childhood HTN are thought to
continue into adulthood, placing these patients at
substantial risk for serious CV disease. Early indicators
of impaired CV health, such as increased BPV, may
prove to be important risk factors for CV disease in the
pediatric population. The purpose of this study was to
examine potential differences in 24-hour BPV between
pediatric patients with primary vs secondary HTN. In
addition, we sought to determine the relationship
between BPV with left ventricular mass index (LVMI)
and LVH in these two groups.
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MATERIALS AND METHODS
Patients
Children diagnosed with HTN, aged 5 to 21 years,
followed by the nephrology division at a single tertiary
care medical center were examined in this retrospective
chart analysis (2010–2013). All patients completed
24-hour ambulatory BP monitoring (ABPM) and echocardiography. Primary HTN was defined as ambulatory
BP >95% for height and sex not attributable to another
cause.14 Secondary HTN was defined as elevated BP
attributed to another cause, which included nephrotic
syndrome, end-stage renal disease, transplantation,
systemic lupus erythematosus, diabetes mellitus, polycystic kidney disease, obstructive uropathy, renal
artery stenosis, apparent mineralocorticoid excess, and
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steroids. Children were diagnosed with secondary HTN
based on radiologic studies, histopathology, genetic
testing, or history of kidney transplant. The study
protocol was approved by the institutional review board
of the North Shore Long Island Jewish Health System.
Informed consent was not obtained because of the
retrospective nature of the study.
BP Variability
Study patients completed 24-hour ABPM using Spacelab 90217 monitors (Spacelabs Medical, Redmond,
WA). Patients taking antihypertensive medications were
kept on their medications during the testing. BP
recordings were programmed to occur every 20 minutes
during the day and every 60 minutes while sleeping.
Sleep and wake times were recorded and adjusted for
each patient to define the nighttime period. The ABPM
study was considered satisfactory for analysis if >75%
of readings were valid during the 24 hours, consistent
with American Heart Association recommendations for
standard ambulatory assessment.15 Measured variables
included systolic and diastolic standard deviation (SD),
average real variability (ARV), and range for the
24-hour, daytime, and nighttime periods. Systolic and
diastolic SDs were calculated from the systolic and
diastolic values, respectively, for each reading. ARV was
defined as the mean absolute difference between discrete
measurements and was calculated as outlined in Levitan
and colleagues.16 The ranges were computed from the
maximum and minimums of the readings.
Echocardiography
All patients underwent standard 2-dimensional and
M-mode echocardiography following the American
Society of Echocardiography pediatric guidelines by an
experienced cardiac ultrasound technician.17 Echocardiograms performed outside of the institution were
excluded. LVMI was calculated from each echocardiogram using measurements of the interventricular septum
(IVS), left ventricular end-diastolic dimension (LVID),
and left ventricular posterior wall (LVPW). The Devereux formula for LV mass was used (LV mass=0.8 (1.04
([IVS+LVID+LVPW]3 LVID3)+0.6))18 and indexed to
height(m)2.7. LVH was defined as LVMI ≥95th percentile for age- and sex-specific reference criteria.19
Statistical Analysis
Descriptive analyses included means, medians, SDs, and
ranges of continuous variables and distributions of
categorical variables. Demographic and clinical variables, systolic and diastolic BPV ARV, SD, and range for
the total monitoring period, wake periods, and sleep
periods were compared between groups (primary vs
secondary HTN) using independent samples t test,
Mann-Whitney, or chi-square analysis. The correlation
between these variables was determined using Pearson
or Spearman correlation coefficients. Anthropometric
and clinical variables with P<.15 on univariate analysis
were tested in stepwise multiple linear regression models
438
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to assess potential predictors of BPV variables. A group
variable (primary vs secondary) was then entered into
the model to determine the association with BPV.
Multiple linear regression models adjusted for age,
BMI z score, and antihypertensive medications (factors
cited in previous literature) were used to examine the
association between BPV and LVMI. BPV variables as
predictors of LVH were tested using logistic regression
models adjusted for age, BMI z score, and antihypertensive medications. Models were tested with groups
combined and then separate for primary and secondary
HTN groups.
While this study involves multiple outcomes, these
outcomes (eg, ARV, SD, and range) are highly correlated and a Bonferonni correction is unduly conservative.20 As such, we set the overall level of significance at
.05, using 2-tailed tests of hypotheses, and examined the
results for consistency across related outcomes. Statistical analyses were performed using SPSS 18.0 (SPSS Inc,
Chicago, IL) statistical package.

RESULTS
The 74 children included 55 boys (74%) and 19 girls
(26%) with a median age of 13.5 years (interquartile
range: 11–16 years). Thirty-four (46%) children had
secondary HTN. The proportion of children with
primary HTN was 54%. Demographic and BPV data
are summarized in the Table. Children with secondary
HTN were taking more antihypertensive medications
(P<.001) and were shorter (P=.02) than patients in the
primary HTN group. In the entire group, overall systolic
ARV ranged from 5.0 mm Hg to 17.9 mm Hg (mean
8.71.9 mm Hg). Overall systolic SD ranged from
4.1 mm Hg to 13.7 mm Hg (mean 7.42.0 mm Hg).
Predictors of BPV
Examining the group as a whole, BMI z score and
weight were significantly correlated with measures of
ARV and SD. The strongest relationship was found
between BMI z score and overall diastolic ARV (r=0.48;
P<.001). Similar relationships were found between BMI
z score and systolic and diastolic ARV and SD in the
overall and wake periods, but not during the sleep
period (r=0.23–0.48, all P<.05), suggesting that patients
with higher BMI values experienced greater BP variability. Comparable results were found for weight
during the overall, wake, and sleep periods (r=0.24–
0.4, all P<.05). Age was found to be significantly
correlated with sleep period systolic ARV (r=0.29,
P=.017), SD (r=0.34, P=.005), and range (r=0.34,
P=.004). Use of antihypertensive medications was not
associated with any BPV measures. In a multivariate
regression model (R2=0.14), BMI z score (b=0.55; 95%
confidence interval [CI], 0.10–0.99; P=.02) and age
(b=0.16; 95% CI, 0.02–0.3; P=.02) were found to be
independent predictors of overall systolic ARV. BMI z
score (b=0.52; 95% CI, 0.12–0.92; P=.01) and age
(b=0.15; 95% CI, 0.02–0.27; P=.025) were also independent predictors of overall systolic SD (R2=0.39).
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medications. There were no other significant associations of BPV measures with either primary or secondary
HTN.

TABLE. Demographic and Blood Pressure
Variability Data
Demographic Data

Overall

No. (%)
Age, y

74

Primary

Secondary

HTN

HTN

40 (54)

34 (46)

P Value

13.33.8

13.63.6

12.94.0

.46

Men, No. (%)
Height, cm

55 (74)
159.319.9

32 (80)
164.117.6

23 (68)
153.121.1

.15
.02

Weight, kg
BMI z score

65.228.9
1.11.2

70.729.5
1.21.2

58.827.2
1.01.3

.08
.58

LVMI, g/m2.7
LVH, No. (%)

36.79.1
23 (31)

35.410.0
11 (28)

38.27.9
12 (35)

.20
.41

16 (22)

2 (5)

14 (41)

<.001

8.91.7
7.72.2

8.42.2
7.01.9

.19
.22

49.913.0

44.612.3

.43

9.42.5
8.02.2

8.82.2
7.41.8

.29
.17

49.716.4

45.212.4

.2

8.92.0
7.52.3

8.32.3
7.53

.29
.9

40.012.0

.31

9.73.1
8.12.3

8.72.0
7.41.7

.15
.19

46.217.2

41.611.0

.19

10.34.3
7.53.7

8.43.1
6.52.4

.04
.21

31.514.1

30.513.8

.77

9.23.7
7.13.0

9.03.5
6.82.7

9.53.9
7.43.3

.64
.39

32.117.7

29.214.0

35.921.1

.12

Antihypertensive
medications,

No. (%)
Overall systolic, mm Hg
ARV
SD

8.71.9
7.42.0

Range
46.214.9
Overall diastolic, mm Hg
ARV
SD

9.12.4
7.82.0

Range
47.714.8
Wake period systolic, mm Hg
ARV
SD

8.62.2
7.52.7

Range
41.914.4
Wake period diastolic, mm Hg
ARV
SD

9.22.7
7.82.1

Range
44.214.9
Sleep period systolic, mm Hg
ARV
SD

9.53.9
7.03.2

Range
31.113.9
Sleep period diastolic, mm Hg
ARV
SD
Range

43.516

Abbreviations: ARV, average real variability; BMI, body mass index;
HTN, hypertension; LVH, left ventricular hypertrophy; LVMI, left
ventricular mass index; SD, standard deviation. Bold values indicate
significance.

BPV in Primary vs Secondary HTN
The sleep period systolic ARV was significantly higher
in the primary HTN group than in the secondary HTN
group (10.34.3 vs 8.43.1, P=.04), but when children
taking antihypertensive medications were excluded,
sleep period diastolic SD was significantly higher in
the secondary HTN group than in the primary HTN
group (9.263.8 vs 7.12.8, P=.039). There were no
other statistically significant differences in BPV measures between the secondary and primary HTN groups
(Table). In multiple regression analysis, secondary HTN
was associated with increased sleep period diastolic SD
(b= 2.1; 95% CI 3.8 to 0.27; P=.025) after adjustment for age, BMI z score, and antihypertensive

Left Ventricular Hypertrophy
Among the 74 children, we also examined the relationship between LVMI and BPV using multiple linear
regression analysis. Systolic ARV adjusted for age, BMI
z score, and antihypertensive medications did not
predict LVMI (b= 0.22; 95% CI,
1.5 to 1.1;
P=.75). No other metrics of BPV in the overall, wake,
and sleep periods were found to be significantly associated with LVMI. However, when examining the
primary HTN group alone, an increase in wake period
systolic SD was found to be significantly associated with
increased LVMI after adjustment for confounders
(b=1.7; 95% CI, 0.133–3.2; P=.034). In addition,
increased wake period diastolic ARV (b=1.3; 95% CI,
0.075–2.6; P=.039) was significantly associated with
increased LVMI. No associations were found for the
secondary HTN group alone.
In multiple logistic regression, measures of BPV were
evaluated as independent predictors of LVH status.
Among the whole group, overall systolic ARV did not
prove to be a significant predictor of LVH (OR, 0.97;
CI, 0.74–1.2; P<.83). This was the case for overall
systolic SD and range as well as the corresponding wake
period values for all 3 BPV metrics. Furthermore, these
metrics were unable to predict LVH status even when
examining both the primary hypertensive group as well
as the secondary hypertensive group exclusively.

DISCUSSION
To our knowledge, the effect of primary vs secondary
hypertensive status on BPV and subsequent outcome has
not previously been described in adults or children. We
felt this to be an important avenue to explore, particularly for this population, because of the character of
both forms of HTN in children in adolescents. Specifically, secondary HTN tends to be more closely associated with unfavorable risk factors (eg, higher systolic
BP, decreased nocturnal dip, nocturnal HTN), but
primary HTN is more associated with increased BMI
in children.1,2,21–32 This study sought to determine
differences in 24-hour BPV between pediatric patients
with primary vs secondary HTN as well as to examine
the relationship of BPV with LVMI and LVH in these
two groups. We hypothesized that BPV would be
different between the groups and could potentially
become a variable to aid in the diagnosis and management of primary vs secondary HTN.
Overall, our results did not demonstrate robust
differences in 24-hour BPV between pediatric patients
with primary vs secondary HTN with the exception of
the association of secondary HTN with sleep period
diastolic BPV. The findings of this study also failed to
indicate a relationship between BPV and LVH in any
group, suggesting that BPV is not a good predictor of
heart target organ damage in children and adolescents.
The Journal of Clinical Hypertension
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However, greater wake period systolic BPV was found
to be associated with increased LVMI in primary
hypertensive children alone. Last, we found that BPV
has a positive correlation with BMI, a well-established
risk factor for all-cause morbidity and mortality, and
CV problems in particular in adulthood.31–34 Interestingly, the degree of overall ARV and SD showed a
positive correlation with age, suggesting that older
hypertensive patients experienced greater BPV.
While BPV has been well described in the adult
literature, the significance of BPV in children and
adolescents is not well defined. Twenty-four–hour BPV
has been tied to CV risk, renal disease progression, and
impaired endothelial and smooth muscle function in
adults.3,7 Additionally, these studies have found BPV to
be a substantial risk factor for these outcomes independent of HTN.4,8,9 The literature has generally suggested
that the systolic component of BPV exhibits more of an
interaction with determinants of CV health than does its
diastolic counterpart.35 Interestingly, though, we found
that increased diastolic BPV during the nighttime was
found to be significant in patients with secondary
hypertension. Children with secondary HTN have been
shown to be prone to both diastolic HTN and nocturnal
HTN.1,2,26–30 Therefore, our findings that children with
secondary HTN experienced greater sleep period diastolic BPV than those with primary HTN warrant
further attention.
In adults, greater 24-hour BPV has been associated
with left ventricular systolic dysfunction in newly
diagnosed hypertensive patients.11 While most research
has suggested that BPV has prognostic value for many
stages of CV disease, it is worth noting that a recent
Russian study in adults found that 24-hour BPV did not
independently predict LVH.36 Also in agreement with
our findings, a recent pediatric study found only a weak
association between 24-hour BPV and LVMI, and found
no relationship between 24-hour BPV and LVH in
children evaluated for hypertension.37 Another pediatric
study examined the relationship of 24-hour BPV and
LVH in pediatric patients with HTN.38 Investigators
determined that daytime systolic SD had significant
associations with LVMI after adjustment for age, sex,
and BMI z score. However, the study examined only a
single measure of variability, SD, as opposed to our
study, which included a more direct measure of discrete
variability, namely ARV. Furthermore, this study examined only primary hypertensive patients, and excluded
individuals who experienced secondary HTN.

STUDY LIMITATIONS
The limitations of this study include sample size and the
inability to look at long-term BPV data in these patients
because of the retrospective nature of the study. While it
would have been ideal to be able to examine both longand short-term BPV, we feel important information can
be garnered solely from the 24-hour BPV, as the latter
has been shown to be independent of visit-to-visit BPV
and independently predictive of adverse outcomes in
440

The Journal of Clinical Hypertension

Vol 16 | No 6 | June 2014

adults. The most significant limitation is the reliance on
LVH as a surrogate outcome measure because of the
nature of CV disease in children and adolescents.

CONCLUSIONS
Our findings suggest that there is no relationship
between BPV and LVH in children, which contrasts
with the substantial volume of literature linking BPV
with CV health in adults. Thus, BPV may not hold the
same clinical relevance in pediatric patients. Admittedly,
some of the issue may lie in the reliance on surrogate
markers of CV disease in this population. This possibility could stem from the nature of CV illness in
children, specifically their shorter exposure to adverse
vascular strain. It is also possible that variability
increases with age and increased BMI as suggested by
our study, perhaps implying that BPV is also a
phenomenon symptomatic of prolonged CV strain.
Additionally, while we conclude that there is no
difference in overall and wake period BPV for patients
with primary vs secondary HTN, we feel the increased
sleep period diastolic BPV in the secondary group
deserves further investigation. Future studies should
seek to confirm these results in a larger population.
Additionally, longitudinal study may be warranted to
determine whether higher BPV in children exhibits
interaction on outcome in adulthood, despite a possible
benign nature in children and adolescents.
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